Is a
Clinical Study attributes
NCT Number
Trial Recruitment Size
100
Trial Sponsor
Clinical Trial Start Date
February 18, 2019
0Primary Completion Date
July 20, 2020
0Study Completion Date
July 20, 2020
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Other0
Drug0
Intervention Name
Experimental dosing of labetalol0
Standard dosing of labetalol0
Interventional Trial Phase
Phase 40
Official Name
Acute Control of Chronic Hypertension in Preeclampsia0
Last Updated
July 22, 2020
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Double0
Masked Party
Investigator0
Outcomes Assessor0
Study summary
The purpose of this study is to understand if administration of a personalized dose of the anti-hypertensive medication, labetalol, based on patient's history of preexisting hypertension, will be more effective at controlling severe hypertension during pregnancy, compared to the current standard dosing.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
